{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:44:57Z","timestamp":1758127497996},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.schres.2023.08.004","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T20:07:17Z","timestamp":1692302837000},"update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A systematic chart review of pharmacological interventions in patients with clozapine-induced hypersalivation"],"prefix":"10.1016","author":[{"given":"Emre","family":"Mutlu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u00e7in","family":"\u00d6z\u00e7elik Ero\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. \u00d6zlem","family":"Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do\u011fukan","family":"Ko\u00e7yi\u011fit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130rem K.N.","family":"Canpolat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanife","family":"Avc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayg\u00fcn","family":"Ertu\u011frul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Elif","family":"An\u0131l Ya\u011fc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.schres.2023.08.004_bb0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1192\/bjp.163.2.150","article-title":"The safety and efficacy of clozapine in severe treatment-resistant schizophrenic patients in the UK","volume":"163","author":"Adams","year":"1993","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.08.004_bb0010","series-title":"Applied Multivariate Statistical Methods","author":"Alpar","year":"2021"},{"issue":"1","key":"10.1016\/j.schres.2023.08.004_bb0015","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2022.630","article-title":"Efficacy of sofpironium bromide gel on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: double-blind, controlled crossover study","volume":"9","author":"Amano","year":"2023","journal-title":"BJPsych Open"},{"key":"10.1016\/j.schres.2023.08.004_bb0020","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.schres.2023.08.004_bb0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2022.02.035","article-title":"Amitriptyline for clozapine-induced hypersalivation: a case series","volume":"243","author":"Cereda","year":"2022","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2023.08.004_bb0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40263-019-00612-8","article-title":"Treatment strategies for clozapine-induced sialorrhea: a systematic review and meta-analysis","volume":"33","author":"Chen","year":"2019","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.schres.2023.08.004_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-2005-837771","article-title":"Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report","volume":"38","author":"Croissant","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/j.schres.2023.08.004_bb0040","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1111\/odi.12139","article-title":"Parasympathetic vasoactive intestinal peptide (VIP): a likely contributor to clozapine-induced sialorrhoea","volume":"20","author":"Ekstr\u00f6m","year":"2014","journal-title":"Oral Dis."},{"key":"10.1016\/j.schres.2023.08.004_bb0045","series-title":"ECDEU Assessment Manual for Psychopharmacology (Revised)","author":"Guy","year":"1976"},{"issue":"05","key":"10.1016\/j.schres.2023.08.004_bb0050","first-page":"316","article-title":"A double-blinded placebo-controlled trial on the use of propantheline in clozapine-induced sialorrhoea","volume":"25","author":"H.","year":"1999","journal-title":"Chin. J. Neuropsychiatr. Dis."},{"issue":"9929","key":"10.1016\/j.schres.2023.08.004_bb0055","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(13)62036-X","article-title":"Schizophrenia: an integrated sociodevelopmental-cognitive model","volume":"383","author":"Howes","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.schres.2023.08.004_bb0060","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18com12123","article-title":"Clinical guidance on the identification and management of treatment-resistant schizophrenia","volume":"80","author":"Kane","year":"2019","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2023.08.004_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.08.004_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/24750573.2017.1347601","article-title":"Tropicamide ophthalmic solution reduces clozapine-induced sialorrhea: a case report","volume":"27","author":"Kilic","year":"2017","journal-title":"Psychiatry Clin. Psychopharmacol."},{"issue":"44","key":"10.1016\/j.schres.2023.08.004_bb0075","first-page":"23","article-title":"Pozitif ve Negatif Sendrom \u00d6l\u00e7e\u011finin (PANSS) T\u00fcrk\u00e7e uyarlamas\u0131n\u0131n ge\u00e7erlilik ve g\u00fcvenilirli\u011fi","volume":"14","author":"Kostako\u011flu","year":"1999","journal-title":"T\u00fcrk Psikoloji Dergisi"},{"issue":"2","key":"10.1016\/j.schres.2023.08.004_bb0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.yic.0000188216.92408.69","article-title":"Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study","volume":"21","author":"Kreinin","year":"2006","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.schres.2023.08.004_bb0085","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3109\/15622975.2010.527370","article-title":"Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation","volume":"12","author":"Kreinin","year":"2011","journal-title":"World J. Biol. Psychiatry"},{"issue":"2 Suppl","key":"10.1016\/j.schres.2023.08.004_bb0090","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2023.08.004_bb0095","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.schres.2010.02.1060","article-title":"Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study","volume":"119","author":"Liang","year":"2010","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2023.08.004_bb0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12888-022-03940-0","article-title":"A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH)","volume":"22","author":"Livermore","year":"2022","journal-title":"BMC Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.schres.2023.08.004_bb0105","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jns.2011.05.021","article-title":"A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson\u2019s disease patients","volume":"310","author":"Lloret","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.schres.2023.08.004_bb0110","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/2045125316641019","article-title":"Clozapine-induced hypersalivation: an estimate of prevalence, severity and impact on quality of life","volume":"6","author":"Maher","year":"2016","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2023.08.004_bb0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/JCP.0000000000000657","article-title":"The effect of glycopyrrolate on nocturnal sialorrhea in patients using clozapine: a randomized, crossover, double-blind, placebo-controlled trial","volume":"37","author":"Man","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2023.08.004_bb0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/JCP.0000000000001655","article-title":"Treatment of clozapine-associated sialorrhea: the role of benzamide derivatives","volume":"43","author":"Miodownik","year":"2023","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.schres.2023.08.004_bb0125","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1007\/s00213-020-05627-4","article-title":"The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial","volume":"237","author":"Mubaslat","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2023.08.004_bb0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5152\/pcp.2022.21221","article-title":"Pharmacokinetics and effects on saliva flow of sublingual and oral atropine in clozapine-treated and healthy adults: an interventional cross-over study","volume":"32","author":"Mubaslat","year":"2022","journal-title":"Psychiatr. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2023.08.004_bb0135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2125.2006.02748.x","article-title":"Amitriptyline for clozapine-induced nocturnal enuresis and sialorrhoea","volume":"63","author":"Praharaj","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2023.08.004_bb0140","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0269881105053311","article-title":"Is clonidine useful for treatment of clozapine-induced sialorrhea?","volume":"19","author":"Praharaj","year":"2005","journal-title":"J. Psychopharmacol. (Oxford Engl.)"},{"issue":"3","key":"10.1016\/j.schres.2023.08.004_bb0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00213-005-0248-4","article-title":"Clozapine-induced sialorrhea: pathophysiology and management strategies","volume":"185","author":"Praharaj","year":"2006","journal-title":"Psychopharmacology"},{"issue":"02","key":"10.1016\/j.schres.2023.08.004_bb0150","first-page":"103","article-title":"The use of topical Wu Dan San on acupuncture points inclozapine-induced sialorrhoea","volume":"08","author":"Qian","year":"1996","journal-title":"Shanghai Arch. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2023.08.004_bb0155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/YIC.0000000000000044","article-title":"Pharmacological and behavioral management of some often-overlooked clozapine-induced side effects","volume":"29","author":"Sagy","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2023.08.004_bb0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-022-06294-3","article-title":"Prevalence of clozapine-induced sialorrhea and its effect on quality of life","volume":"240","author":"Sanagustin","year":"2023","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.schres.2023.08.004_bb0165","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40262-020-00944-5","article-title":"Elevated clozapine concentrations in clozapine-treated patients with hypersalivation","volume":"60","author":"Schoretsanitis","year":"2021","journal-title":"Clin. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.schres.2023.08.004_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ph15070817","article-title":"Adverse drug reactions in relation to clozapine plasma levels: a systematic review","volume":"15","author":"Skokou","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"8","key":"10.1016\/j.schres.2023.08.004_bb0175","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.4088\/JCP.08m04495","article-title":"Treatment of clozapine-induced hypersalivation with ipratropium bromide: a randomized, double-blind, placebo-controlled crossover study","volume":"70","author":"Sockalingam","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2023.08.004_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23082087","article-title":"Current concepts and treatments of schizophrenia","volume":"23","author":"St\u0119pnicki","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.schres.2023.08.004_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005579.pub2","article-title":"Pharmacological interventions for clozapine-induced hypersalivation","author":"Syed","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.schres.2023.08.004_bb0190","series-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor","year":"2021"},{"issue":"11","key":"10.1016\/j.schres.2023.08.004_bb0195","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/ccr3.2431","article-title":"The sublingual use of atropine in the treatment of clozapine-induced sialorrhea: a systematic review","volume":"7","author":"Van der Poorten","year":"2019","journal-title":"Clin. Case Rep."},{"issue":"1","key":"10.1016\/j.schres.2023.08.004_bb0200","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00213-017-4795-2","article-title":"Botulinum toxin: a novel therapy for clozapine-induced sialorrhoea","volume":"235","author":"Verma","year":"2018","journal-title":"Psychopharmacology"},{"issue":"02","key":"10.1016\/j.schres.2023.08.004_bb0205","first-page":"34","article-title":"A controlled trial on the use of Zhiyan capsule in clozapine-induced sialorrhoea","volume":"12","author":"Zhao","year":"2000","journal-title":"Med. J. Chin. Civ. Admin."},{"key":"10.1016\/j.schres.2023.08.004_bb0210","first-page":"300","article-title":"A double blinded control study of the effectiveness of doxepin and propatheline in the treatment of clozapine-induced hypersalivation","volume":"6","author":"Zhou","year":"1996","journal-title":"J. Clin. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423002621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423002621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T02:06:53Z","timestamp":1693015613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996423002621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":42,"alternative-id":["S0920996423002621"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2023.08.004","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic chart review of pharmacological interventions in patients with clozapine-induced hypersalivation","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2023.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}